Purdue researchers apply new technique to manipulate virus, make it a possible cancer treatment
November 27, 2013
WEST LAFAYETTE, Ind. — Purdue University researchers successfully eliminated the native infection preferences of a Sindbis virus engineered to target and kill cancer cells, a milestone in the manipulation of this promising viral vector.
"This virus had been known to be a good vector for delivering therapeutic cargo, however it naturally infected all kinds of cells, and these diversions would compete with what we were instructing it to target," said Richard Kuhn, the Gerald and Edna Mann Director of Purdue's Bindley Biosciences Center. "We have now overcome a major challenge by not only inserting a targeting molecule of our choice, but also successfully stripping the virus of its native entry preferences. This was a big step in unlocking the potential of developing this virus into a platform for both targeted drug delivery, where it would sneak drugs inside cancer cells, and oncolytic virotherapy, where the virus itself destroys cancer cells."
- Elizabeth K. Gardner, Writer
April 23, 2014
Purdue University researchers have developed a way to detect and measure cancer levels in a living cell by using tiny gold particles with tails of synthetic DNA.Read Full Story
April 22, 2014
New "plasmonic metamaterials" that operate at high temperatures could radically improve solar cell performance and bring advanced computer data storage technology that uses heat to record information on a magnetic disk.Read Full Story
April 21, 2014
An internal search is underway for the next Director of the Purdue Climate Change Research Center (PCCRC) in Discovery Park. The Director of the PCCRC will lead the Center in its mission and will be responsible for all internal and external affairs oRead Full Story